Answers are grounded in this paper and cite their sources.
Reports real-world evidence on treatment choice in CLL, highlighting distinct patient groups.
This study is the first to report real-world evidence on treatment choice in first-line CLL and highlight two distinct groups of patients.
No takes yet. Share an insight, caveat, or question.
Coste et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: